Cargando…

Treatment with IL5-/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)

PURPOSE: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe delayed drug hypersensitivity reaction with exanthema, eosinophilia, and organ manifestations. After culprit drug withdrawal, systemic corticosteroids (CS) are the most widely used treatment, often requiring high dose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gschwend, Anna, Helbling, Arthur, Feldmeyer, Laurence, Mani-Weber, Ulrich, Meincke, Cordula, Heidemeyer, Kristine, Bossart, Simon, Jörg, Lukas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Medizin 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396594/ https://www.ncbi.nlm.nih.gov/pubmed/36035809 http://dx.doi.org/10.1007/s40629-022-00224-7

Ejemplares similares

Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Jörg, Lukas, et al.
Publicado: (2020)

Tineа Corporis with Trichophyton Rubrum Mimicking a Flare-Up of Psoriasis UnderTreatment with IL17-Inhibitor Ixekizumab
por: Emelianov, Vladimir, et al.
Publicado: (2021)

Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy
por: Feldmeyer, Laurence, et al.
Publicado: (2016)

Canakinumab leads to rapid reduction of neutrophilic inflammation and long-lasting response in Schnitzler syndrome
por: Bossart, Simon, et al.
Publicado: (2023)

Long-Term Dose Optimization of Adalimumab via Dose Spacing in Patients with Psoriasis
por: Benzaquen, Michael, et al.
Publicado: (2022)

Dimethyl Fumarate Used as an Effective Treatment for Granuloma Annulare Disseminatum: An Immunohistochemical Case Study
por: Gabutti, Max, et al.
Publicado: (2023)

75% negative skin test results in patients with suspected hypersensitivity to beta-lactam antibiotics: Influencing factors and interpretation of test results
por: Joerg, Lukas, et al.
Publicado: (2021)

T2-high Asthma, Classified by Sputum mRNA Expression of IL4, IL5, and IL13, is Characterized by Eosinophilia and Severe Phenotype
por: Rijavec, Matija, et al.
Publicado: (2021)

Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients
por: Šokić, Maruša Kopač, et al.
Publicado: (2022)

Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome
por: Rubin, Limor, et al.
Publicado: (2023)

Domestic Parasitic Infections in Patients with Asthma and Eosinophilia in Germany – Three Cases with Learnings in the Era of Anti- IL5 Treatments
por: Barnikel, Michaela, et al.
Publicado: (2023)

Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia
por: Boberg, Emma, et al.
Publicado: (2020)

Intrinsic Defect in T Cell Production of Interleukin (IL)-13 in the Absence of Both IL-5 and Eotaxin Precludes the Development of Eosinophilia and Airways Hyperreactivity in Experimental Asthma
por: Mattes, Joerg, et al.
Publicado: (2002)

Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3(+) Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis
por: Abo, Hirohito, et al.
Publicado: (2019)

Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS)
por: Gill, Shaman, et al.
Publicado: (2013)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in children
por: Francesca, Mori, et al.
Publicado: (2019)

Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia
por: Hatchwell, Luke, et al.
Publicado: (2015)

A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia
por: Pierini, Valentina, et al.
Publicado: (2022)

IL-33–mediated Eosinophilia Protects against Acute Lung Injury
por: Krishack, Paulette A., et al.
Publicado: (2021)

Delayed hypersensitivity reaction to orodispersible budesonide in a case with eosinophilic esophagitis
por: Andrist, Caroline Michèle, et al.
Publicado: (2020)

Successful treatment with the IL12/IL23 antagonist ustekinumab in a patient with refractory Takayasu arteritis
por: Saur, Sebastian-Jonas, et al.
Publicado: (2021)

Griseofulvin associated with drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Maiolo, Corinne, et al.
Publicado: (2016)

Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Sharpe, Alexis, et al.
Publicado: (2019)

Valproate-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
por: Dwivedi, Arun Kumar, et al.
Publicado: (2018)

Editorial: Updates in drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Janela, Baptiste, et al.
Publicado: (2023)

Probable DRESS syndrome induced by IL-1 inhibitors
por: Polivka, L., et al.
Publicado: (2017)

Fulminant Type 1 Diabetes in the Course of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome
por: Dubois-Laforgue, Danièle, et al.
Publicado: (2013)

Macrophages-induced IL-18–mediated eosinophilia promotes characteristics of pancreatic malignancy
por: Kandikattu, Hemanth Kumar, et al.
Publicado: (2021)

Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Severe ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Picard, Matthieu, et al.
Publicado: (2011)

Eosinophilia in pre-anesthetic assessment: A guide to diagnosis of DRESS syndrome
por: Bansal, Shivendu, et al.
Publicado: (2013)

Ivermectin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
por: Kerneuzet, Ines, et al.
Publicado: (2018)

Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19
por: Ramirez, Giuseppe A., et al.
Publicado: (2021)

An investigation into the avoidability of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2021)

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation
por: Cho, Ara, et al.
Publicado: (2021)

Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Due to Vancomycin
por: Kulkarni, Mugdha P, et al.
Publicado: (2022)

IL-33 Enhanced the Proliferation and Constitutive Production of IL-13 and IL-5 by Fibrocytes
por: Hayashi, Hisako, et al.
Publicado: (2014)

Targeting IL-5 in COPD
por: Narendra, Dharani K, et al.
Publicado: (2019)

Eosinophils, beyond IL-5
por: Esnault, Stephane, et al.
Publicado: (2021)

Systematic review: IL-12/23 or IL-23 antagonists and RTIs or ILD
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rfh3tj513143b70u5mtra24k42